Urothelial carcinoma

Urothelial carcinoma is a type of cancer that typically occurs in the urinary system. It begins in specific cells that are called urothelial cells. These cells line the urethra, bladder, ureters, renal pelvis, and some other organs. Urothelial cells are also called transitional cells. These cells can change shape and stretch without breaking apart.

Showing all 3 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PD-L1
Monoclonal Antibody-Fc engineered
Tecentriq®
60 mg/mL
yes
12 mg
-80°C
03/2022
262,80 
view product
Max: 10
Min: 2
Step: 1
PD-L1
Monoclonal Antibody-Fc engineered
Tecentriq®
60 mg/mL
yes
12 mg
-80°C
05/2023
262,80 
view product
Max: 6
Min: 2
Step: 1
PD-L1
Monoclonal Antibody
Bavencio®
20 mg/mL
2 mg
-80°C
01/2021
125,10 
view product
Max: 10
Min: 3
Step: 1

Not looking for Urothelial carcinoma?

Search our therapeutic molecules product database